The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease

Status Completed

Clinical Trial Summary

Behçet's Disease(BD) is a systemic inflammatory vasculitis, which affects all types and sizes of vessels. Statins display numerous effects often independent of the well-established lipid-lowering effects that may be of benefit in retarding or preventing vascular injury and ischaemic vascular events. The aim of the present study was to determine the efficacy of rosuvastatin in improving vascular dysfunction and vascular inflammation and to assess the effect of rosuvastatin on vascular involvement in BD patients. Fifty-six BD patients (51 males and 5 females) mean age 33.4 years, mean disease duration 5.8 years), all fulfilling the classification criteria of the International Study Group for Behçet's disease were recruited.Patients were randomised into 2 groups.

The first group (n=27: 20 active and 7 inactive) were assigned to receive 40 mg of rosuvastatin and the second group(n=29: 21 active and 8 inactive) received placebo for 12 months. Inflammatory and endothelial dysregulation markers were measured at baseline and after 12 months. All patients were examined for vascular involvement. Venous or arterial system involvement was defined as present when confirmed by Doppler ultrasonography, magnetic resonance angiography, conventional angiography or CT.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04328064
Study type	Interventional
Source	University of Alexandria
Contact
Status	Completed
Phase	N/A
Start date	May 2010
Completion date	June 2011

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05635266` - A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed	`NCT02190916` - Vasculitis Illness Perception (VIP) Study	N/A
Completed	`NCT04065672` - Low-dose IL-2 Treatment on Behcet's Disease	Phase 2
Recruiting	`NCT02593565` - Vasculitis Pregnancy Registry
Completed	`NCT00167583` - Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)	Phase 3
Completed	`NCT03371095` - Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease	Phase 3
Completed	`NCT01960790` - Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Completed	`NCT03531385` - Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease
Completed	`NCT02190942` - VCRC Patient Contact Registry Patient-Reported Data Validation Study
Not yet recruiting	`NCT06285539` - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases	Phase 2
Completed	`NCT02190929` - Educational Needs of Patients With Systemic Vasculitis	N/A
Completed	`NCT02476292` - Impact of Vasculitis on Employment and Income	N/A
Completed	`NCT03543709` - Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease
Recruiting	`NCT01793168` - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed	`NCT01988506` - Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases	Phase 2
Recruiting	`NCT01952275` - Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases	N/A
Completed	`NCT01532570` - Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions	Phase 3
Completed	`NCT03410290` - Journey of Patients With Vasculitis From First Symptom to Diagnosis
Completed	`NCT02176070` - Reproductive Health in Men and Women With Vasculitis	N/A
Recruiting	`NCT01306955` - The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease	Phase 4